89
Views
0
CrossRef citations to date
0
Altmetric
Short Reports

Impressive neurological recovery following C-spine dislocation in a patient on long term immunosuppression

, , &
Pages 771-773 | Received 10 Mar 2019, Accepted 06 Jun 2019, Published online: 19 Jun 2019

References

  • Spinal injury: assessment and initial management | Guidance and guidelines | NICE [Internet]. Nice.org.uk; 2017. Available from: https://www.nice.org.uk/guidance/ng41
  • Feuchtbaum E, Buchowski J, Zebala L. Subaxial cervical spine trauma. Curr Rev Musculoskeletal Med 2016;9:496–504.
  • van Middendorp J, Hosman A, Pouw M, Van de Meent H. ASIA impairment scale conversion in traumatic SCI: is it related with the ability to walk? A descriptive comparison with functional ambulation outcome measures in 273 patients. Spinal Cord 2008;47:555–60.
  • Marino R, Ditunno J, Donovan, W, Maynard, F. Neurologic recovery after traumatic spinal cord injury: data from the model spinal cord injury systems. Arch Phys Med Rehab 1999;80:1391–6.
  • Ibarra A, Correa D, Willms K, et al. Effects of cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury. Brain Research 2003;979:165–78.
  • López-Vales R, García-Alías G, Forés J, et al. FK506 reduces tissue damage and prevents functional deficit after spinal cord injury in the rat. Journal of Neuroscience Research, 2005;81:827–36.
  • Cai, J., Sun, Y., Yin, Z., et al. Analysis of FK506-mediated functional recovery and neuroprotection in a rat model of spinal cord injury indicates that EGF is modulated in astrocytes. Exp Ther Med. 2018;16(2):501–510.
  • Furuichi Y, Maeda M, Moriguchi A, et al. Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primates. J Cerebr Blood F Met 2003;23:1183–94.
  • Wang P, He X, Ma J, et al. Brain injury in combination with tacrolimus promotes the regeneration of injured peripheral nerves. Neural Regen Res 2017;12:987.
  • Bracken M. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA, 1997;277:1597–604.
  • Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: results of the Second National Acute Spinal Cord Injury Study. New England Journal of Medicine, 1990;322:1405–11.
  • Bracken M, Shepard M, Hellenbrand K. 'Methylprednisolone and neurological function1 year after spinal cord injury. Results of the NationalAcute Spinal Cord Injury Study. J Neurosurg 1985;63:704–13.
  • Hurlbert R. Methylprednisolone for the Treatment of Acute Spinal Cord Injury. Neurosurgery 2014;61:32–5.
  • Walters B, Hadley M, Hurlbert R, et al. Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery 2013;60:82–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.